Terms: = Breast cancer AND BRCA1, BRCAI, 672, ENSG00000012048, IRIS, BRCC1, RNF53, PSCP
10766 results:
1. Using Portuguese BRCA pathogenic variation as a model to study the impact of human admixture on human health.
Andaluz S; Zhao B; Sinha S; Lagniton PNP; Costa DA; Ding X; Brito M; Wang SM
BMC Genomics; 2024 Apr; 25(1):416. PubMed ID: 38671360
[TBL] [Abstract] [Full Text] [Related]
2. Women's Knowledge of Genomic Testing and Precision Medicine in breast cancer Treatment Decision-Making.
Robles-Rodriguez E; Houser L; Sanchez B; Ormerod C; Washburn S; Oertle SK; Jerome-D'Emilia B
Oncol Nurs Forum; 2024 Apr; 51(3):199-208. PubMed ID: 38668907
[TBL] [Abstract] [Full Text] [Related]
3. Factors impacting quality of life for breast cancer survivors.
Davis SC; Snyder E
Nurse Pract; 2024 May; 49(5):17-23. PubMed ID: 38662491
[TBL] [Abstract] [Full Text] [Related]
4. CDH1 Genotype Exploration in Women With Hereditary Lobular breast cancer Phenotype.
Corso G; Marino E; Zanzottera C; Oliveira C; Bernard L; Macis D; Figueiredo J; Pereira J; Carneiro P; Massari G; Barberis M; De Scalzi AM; Taormina SV; Sajjadi E; Sangalli C; Gandini S; D'Ecclesiis O; Trovato CM; Rotili A; Pesapane F; Nicosia L; La Vecchia C; Galimberti V; Guerini-Rocco E; Bonanni B; Veronesi P
JAMA Netw Open; 2024 Apr; 7(4):e247862. PubMed ID: 38652475
[TBL] [Abstract] [Full Text] [Related]
5. Postpartum breast cancer and Survival in Women With Germline BRCA Pathogenic Variants.
Zhang Z; Ye S; Bernhardt SM; Nelson HD; Velie EM; Borges VF; Woodward ER; Evans DGR; Schedin PJ
JAMA Netw Open; 2024 Apr; 7(4):e247421. PubMed ID: 38639936
[TBL] [Abstract] [Full Text] [Related]
6. Uptake of Risk-Reducing Measures, Cascade Testing, and Related Challenges Among Carriers of breast cancer-Associated Germline Pathogenic Variants in Mexico.
Mesa-Chavez F; Chavarri-Guerra Y; Aguilar-Y-Mendez D; Becerril-Gaitan A; Vaca-Cartagena BF; Carrillo-Bedoya A; Santiesteban-González S; Aranda-Gutierrez A; Rodríguez-Faure A; Obregon-Leal D; Quintero-Beuló G; Rodriguez-Olivares JL; Miaja M; Weitzel JN; Villarreal-Garza C
JCO Glob Oncol; 2024 Apr; 10():e2300417. PubMed ID: 38635940
[TBL] [Abstract] [Full Text] [Related]
7. A Study on the Retrospective Reinterpretation of brca1 and BRCA2 Variants.
Kim JJ; Kim DJ; Nam EJ; Song KE; Ham JY; Kim YK; Lee NY
Clin Lab; 2024 Apr; 70(4):. PubMed ID: 38623660
[TBL] [Abstract] [Full Text] [Related]
8. PALB2-mutated human mammary cells display a broad spectrum of morphological and functional abnormalities induced by increased TGFβ signaling.
Tuppurainen H; Laurila N; Nätynki M; Eshraghi L; Tervasmäki A; Erichsen L; Sørensen CS; Pylkäs K; Winqvist R; Peltoketo H
Cell Mol Life Sci; 2024 Apr; 81(1):173. PubMed ID: 38597967
[TBL] [Abstract] [Full Text] [Related]
9. Genetic interactions reveal distinct biological and therapeutic implications in breast cancer.
Lin CJ; Jin X; Ma D; Chen C; Ou-Yang Y; Pei YC; Zhou CZ; Qu FL; Wang YJ; Liu CL; Fan L; Hu X; Shao ZM; Jiang YZ
Cancer Cell; 2024 Apr; 42(4):701-719.e12. PubMed ID: 38593782
[TBL] [Abstract] [Full Text] [Related]
10. Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma With BRCA-Like Genomic Aberrations.
Schouten PC; Schmidt S; Becker K; Thiele H; Nürnberg P; Richters L; Ernst C; Treilleux I; Medioni J; Heitz F; Pisano C; Garcia Y; Petru E; Hietanen S; Colombo N; Vergote I; Nagao S; Linn SC; Pujade-Lauraine E; Ray-Coquard I; Harter P; Hahnen E; Schmutzler RK
JAMA Netw Open; 2024 Apr; 7(4):e245552. PubMed ID: 38592722
[TBL] [Abstract] [Full Text] [Related]
11. Selective impact of ALK and MELK inhibition on ERα stability and cell proliferation in cell lines representing distinct molecular phenotypes of breast cancer.
Bartoloni S; Pescatori S; Bianchi F; Cipolletti M; Acconcia F
Sci Rep; 2024 Apr; 14(1):8200. PubMed ID: 38589728
[TBL] [Abstract] [Full Text] [Related]
12. Evaluating homologous recombination activity in tissues to predict the risk of hereditary breast and ovarian cancer and olaparib sensitivity.
Motonari T; Yoshino Y; Haruta M; Endo S; Sasaki S; Miyashita M; Tada H; Watanabe G; Kaneko T; Ishida T; Chiba N
Sci Rep; 2024 Apr; 14(1):7519. PubMed ID: 38589490
[TBL] [Abstract] [Full Text] [Related]
13. CDK inhibition results in pharmacologic BRCAness increasing sensitivity to olaparib in brca1-WT and olaparib resistant in Triple Negative breast cancer.
Orhan E; Velazquez C; Tabet I; Fenou L; Rodier G; Orsetti B; Jacot W; Sardet C; Theillet C
Cancer Lett; 2024 May; 589():216820. PubMed ID: 38574883
[TBL] [Abstract] [Full Text] [Related]
14. Olaparib not cost-effective as maintenance therapy for platinum-sensitive, brca1/2 germline-mutated metastatic pancreatic cancer.
Mehra T; Lupatsch JE; Kössler T; Dedes K; Siebenhüner AR; von Moos R; Wicki A; Schwenkglenks ME
PLoS One; 2024; 19(4):e0301271. PubMed ID: 38573891
[TBL] [Abstract] [Full Text] [Related]
15. Causal association between complement system FHR-5, CTRP9, and breast carcinoma in situ: a Mendelian randomization study.
Peng YL; Li H; Sun P; Zhang HD; Li D; Wang HB; Zhang L
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2363-2371. PubMed ID: 38567599
[TBL] [Abstract] [Full Text] [Related]
16. Population-based BRCA germline mutation screening in the Han Chinese identifies individuals at risk of BRCA mutation-related cancer: experience from a clinical diagnostic center from greater Shanghai area.
Wu Z; Zhang Q; Jin Y; Zhang X; Chen Y; Yang C; Tang X; Jiang H; Wang X; Zhou X; Yu F; Wang B; Guan M
BMC Cancer; 2024 Apr; 24(1):411. PubMed ID: 38566028
[TBL] [Abstract] [Full Text] [Related]
17. Use of a topical Janus kinase inhibitor in immune checkpoint inhibitor-induced eczematous reaction: a case report.
Powers CM; Verma H; Orloff J; Piontkowski AJ; Tiersten A; Lamb A; Gulati N
J Dermatolog Treat; 2024 Dec; 35(1):2336118. PubMed ID: 38565207
[TBL] [Abstract] [Full Text] [Related]
18. Difficulties of gender affirming treatment in trans women with brca1+ mutation: A case report.
Piñar-Gutiérrez A; Dueñas Disotuar S; de Lara-Rodríguez I; Amuedo-Domínguez S; González-Cejudo C; Tejero-Delgado J; Mangas-Cruz MÁ
Endocrinol Diabetes Nutr (Engl Ed); 2024 Mar; 71(3):144-148. PubMed ID: 38555112
[TBL] [Abstract] [Full Text] [Related]
19. cancer trend and radiotherapy utilization at a tertiary academic hospital in Malaysia.
Gan DEH; Bustam AZ
J Cancer Res Ther; 2024 Jan; 20(1):358-362. PubMed ID: 38554346
[TBL] [Abstract] [Full Text] [Related]
20. A single-cell atlas enables mapping of homeostatic cellular shifts in the adult human breast.
Reed AD; Pensa S; Steif A; Stenning J; Kunz DJ; Porter LJ; Hua K; He P; Twigger AJ; Siu AJQ; Kania K; Barrow-McGee R; Goulding I; Gomm JJ; Speirs V; Jones JL; Marioni JC; Khaled WT
Nat Genet; 2024 Apr; 56(4):652-662. PubMed ID: 38548988
[TBL] [Abstract] [Full Text] [Related]
[Next]
